<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>138(19)</volume><submitter>Ruggeri A</submitter><journal>Blood</journal><pagination>672-672</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8701766</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial</pubmed_title><pmcid>PMC8701766</pmcid><pubmed_authors>Sciutti F</pubmed_authors><pubmed_authors>Landoni G</pubmed_authors><pubmed_authors>Ruggeri A</pubmed_authors><pubmed_authors>Rovere-Querini P</pubmed_authors><pubmed_authors>Corrado F</pubmed_authors><pubmed_authors>Richardson P</pubmed_authors><pubmed_authors>Catalano G</pubmed_authors><pubmed_authors>Di Filippo L</pubmed_authors><pubmed_authors>Lunghi F</pubmed_authors><pubmed_authors>Nitti R</pubmed_authors><pubmed_authors>Iacobelli M</pubmed_authors><pubmed_authors>Carlo-Stella C</pubmed_authors><pubmed_authors>Liberatore C</pubmed_authors><pubmed_authors>Fedeli C</pubmed_authors><pubmed_authors>Aghemo A</pubmed_authors><pubmed_authors>Bruno A</pubmed_authors><pubmed_authors>Voza A</pubmed_authors><pubmed_authors>Peccatori J</pubmed_authors><pubmed_authors>Ciceri F</pubmed_authors><pubmed_authors>Assanelli A</pubmed_authors><pubmed_authors>Giglio F</pubmed_authors><pubmed_authors>Calabretta E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-05-29T20:38:40.163Z</modification><creation>2025-05-29T20:38:40.163Z</creation></dates><accession>S-EPMC8701766</accession><cross_references/></HashMap>